ArticleBriefings in bioinformatics2020

Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.

Ying Hong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.